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Abstract 
Western blots of human polymorphonuclear leukocyte (PMN) extracts were immunostained with antibodies specific for various protein kinase 
C (PKC) isoforms. Two bands corresponding to PKC type [with apparent molecular masses of 81 kDa and 76 kDa were identified in the cytosolic 
fraction of resting cells, in addition to PKC types a andb. PKC[ was apparently abundant, like PKC/3, whereas PKCG, -E, and -y were not detectable. 
Following short stimulation (5 min) of PMN with phorbol-12-myristate-13-acetate (I &ml), physical translocation of PKC[ from the cytosol to 
the plasma membrane fraction occurred, although this isoform does not bind phorbol esters. These data show that, in addition to the two 
calcium-dependent isoenzymes a and B, human PMN express a calcium-independent isoenzyme [ which translocates in stimulated cells, suggesting 
a role in the regulation of antibacterial activities, 
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1. Introduction 
Protein kinase C, a family of phospholipid-dependent 
serine/threonine kinases, plays a pivotal role in agonist- 
stimulated cell functions [l-3]. To date, twelve PKC 
isoenzymes have been identified in mammalian tissues 
[4]. They have been classified into three subgroups [5]. 
The conventional PKCs (cPKC) PKCol, $1, $11, and -y 
require PS and are activated by calcium and DAG or 
phorbol esters. The novel PKCs (nPKCs) PKCS, -E, -q 
and -8 do not require calcium and exhibit enzyme activ- 
ities in the presence of PS and DAG. Atypical (aPKC) 
PKCC and -2 are dependent on PS but not DAG, phor- 
bol esters or calcium for activation. Recently, two other 
isoforms, PKCz and -p, have been identified; they may 
belong to the aPKC and nPKC subgroups, respectively 
[6,7]. PKC isoforms show subtly different enzymatic 
properties, different tissue expression, and specific intra- 
cellular locations, suggesting a different role for each 
isoform in cell functions [3-51. 
In a number of cell models, activation of PKC by 
phorbol esters is generally associated with irreversible 
association and conversion of soluble PKC to a particu- 
late or ‘inserted’ form [8-lo]. This translocation of PKC 
has been used as an index of enzyme activation. 
Polymorphonuclear leukocytes (PMN) play an impor- 
*Corresponding author, at the first address. Fax: (33) (1) 4025-8853. 
Abbreviations; DAG, diacylglycerol; PKC, protein kinase C; PMA, 
phorbol myristate acetate; PMN, polymorphonuclear leukocytes; PS, 
phosphatidylserine; SDS, sodium dodecyl sulfate; PAGE, poly- 
acrylamide gel electrophoresis. 
tant role in host defences against microbial infections. A 
role of PKC has been proposed in the regulation of 
antibacterial PMN activities such as superoxide anion 
generation (respiratory burst) and release of granule con- 
tents induced by phorbol esters or chemoattractants 
[l l-141. To date, three PKC isoforms have been charac- 
terized in the human PMN, including two conventional 
calcium-dependent PKC isoforms, PKCa and -/I, and a 
calcium-independent form which requires both PS and 
DAG for optimal activity [15-181. 
In this study, we show that human PMN also express 
a calcium-independent isoform, PKCC, which is mainly 
present in the cytosol of resting cells. In addition, stimu- 
lation of PMN with PMA results in translocation of 
PKCC to membrane fractions, suggesting apotential role 
of PKC[ in PMN antimicrobial activities. 
2. Materials and metbods 
2.1. Materials 
Antibodies against PKCa, -@, -6, -6, -y, and -c were all from Gibco 
BRL (Cergy-Pontoise, France). They were raised in rabbits against 
amino acid sequences of V3 regions (a and B isoforms) and the amino 
acid sequences of V5 regions (6, E, and [ isoforms). Phorbol-I 2-myris- 
tate-13-acetate (PMA), all protease inhibitors and materials for poly- 
acrylamide gel electrophoresis were purchased from Sigma (St. Louis, 
MO). X-Ray films for autoradiography were obtained from Amersham 
International (UK). 
2.2. Cell preparation 
PMN from heparinized venous blood of healthy volunteers were 
isolated as previously described [29] except hat cells were washed with 
phosphate-buffered saline containing 5 mM EDTA to minimize platelet 
contamination [20]. Red cells were removed by hypotonic Iysis, and the 
PMN were washed and resuspended in calcium-free Hanks balanced 
salt solution (HBSS) at pH 7.4. Cell preparations usually contained 98% 
PMN and fewer than 0.5 platelets per PMN. Platelets were prepared 
from human blood as described elsewhere [21]. 
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2.3. Stimulation andfractionation of PMN 
Suspensions of 5 x 10’ PMN/ml were warmed to 37°C and stimu- 
lated for 5 min with 1 &ml PMA or 0.1% dimethyl sulfoxide (vehicle) 
with gentle agitation. Cells were then diluted in four volumes of ice-cold 
buffe; and spun down at 400 x g for 10 min at 4°C. Pellets were resus- 
pended in lysis buffer containing 20 mM Tris-HCI, pH 7.5, 0.25 M 
saccharose, 50 mM 2-mercaptoethanol, 2 mM EDTA, 10 mM EGTA, 
2 mM PMSF and anti-protease mixture consisting of 0.1% leupeptin, 
0.35 mM antipain, 0.24 mg/ml chymostatin, 0.35 mM pepstatin and 
10 fig/ml aprotinin. PMN suspensions were cavitated (450 psi, 20 min) 
at 4°C and the homogenates were centrifuged (400 x g, IO min) to 
remove unbroken cells. The postnuclear supernatant was loaded on a 
discontinuous ucrose gradient (50% sucrose, 30% sucrose) and centri- 
fuged for 1 h at 200,000 x g. The membrane fraction was collected in 
the 30% layer and washed once with lysis buffer. 
3. Results 
Human PMN have been shown to express cPKCa and 
-/I isoforms [15-181. To examine the possibility that 
human PMN express other PKC isoforms, Western blots 
using antipeptide antibodies specific to PKCa, -/I, -y, -6, 
-E, and -c isoforms were performed on cytosolic and 
plasma membrane fractions of resting PMN. All six 
isotypes tested were present in the rat brain cytosolic 
extract, used here as positive control (Fig. 1). We con- 
firmed the presence of immunoreactive PKCa and $3, 
and demonstrated the presence of PKCLJ, which was de- 
tected as two bands (Fig. 1). None of these isoforms were 
observed in the plasma membrane fraction of resting 
cells (Fig. 1) or in the granular fraction (results not 
shown). 
2.4. Western blotting 
Following SDS-PAGE on l&12% acrylamide gels [22], protein was 
transferred to nitrocellulose filters (Hybond-C extra, Amersham). Rat 
brain protein extracts were run in parallel and served as positive con- 
trols for immunodetection of PKC isoforms. Filters were incubated for 
2 h at room temperature in 50 mM Tris, 150 mM NaCI, 0.05% Tween 
20 (TBST) containing 10% (w/v) fat-free dried milk. Nitrocellulose 
membranes were washed with TBST and incubated overnight with 
specific antibodies against PKCGI, -/?, -6, -E, -y and -[, all at a dilution 
of 111000. In some cases, PKC isozyme specific peptides were added to 
the primary antibody solution to block specific isozyme bands. After 
washing (5 x) with TBST, a 1130 000 dilution of horseradish peroxidase- 
labelled anti-rabbit IgG was added for I h at room temperature. The 
blots were developed using ECL western-blotting reagents (Amersham 
UK). Results shown are representative of three separate xperiments. 
The reactivity of PKCC was intense, suggesting that it 
may be expressed at high levels, like PKC/3. This latter 
was present as three components with apparent molecu- 
lar masses of 80,72, and 65 kDa (~80, ~72, ~65). P72 and 
p65 predominated. Immunodetection of all three was 
specifically blocked by PKCj? peptide. Thus, p80 may 
represent intact PKC/3, and p72 and p65 modified forms 
generated by proteolytic cleavage. A doublet of 81 kDa 
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Fig. I. Protein kinase C isoform immunoreactivity in cytosol and membrane fractions from human PMN by Western blot analysis. Cytosolic (c) 
and membrane (m) fractions of PMN were prepared as described in section 2, subjected to SDS-PAGE (50 pg of protein/lane for cytosolic fraction 
and 8Opg of protein/lane for membrane fraction). Proteins were transferred to nitrocellulose and immunoblotted with antipeptide antibodies pecific 
to PKCa, -B, -6, -y. -E, and -<. To confirm the specificity of staining, antisera were preincubated with (+) and without (-) the appropriate peptide 
antigen. Each left lane corresponds to a rat brain cytosolic fraction as a positive control. 
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Fig. 2. Comparison of PKC isofonns in cytosol from human PMN and human platelets by Western blot analysis. Cytosolic fractions were prepared 
as described in section 2, subjected to SDS-PAGE (50 pg of protein/lane), transferred to nitrocellulose, and immunoblotted with antibodies specific 
to PKCa and PKC<. The amount of soluble protein correspond to a cell equivalent of 5 x lo6 PMN and 75 x lo6 platelets. Each left lane contains 
a rat brain cytosolic fraction as a positive control. 
and 76 kDa was recognized by the antibody against 
PKCC and was eliminated when the primary antibody 
was incubated with the peptide antigen used to generate 
the antibody. Both bands could correspond to PKCC 
since the existence of additional PKCC forms is predicted 
by genomic Southern blot analysis [23]. In the rat brain 
cytosolic extract, a lower molecular weight band (51 
kDa) displaced by the PKCC peptide was also recognized 
by the PKCC antibody. This band could correspond to 
PKM form of PKCC. The PKCcl antibody revealed a 
faint immunoreactive band of 80 kDa. No band was 
observed when Western blots were performed with anti- 
bodies specific for PKCG, -E and -y. 
Because the PMN preparation used here contained up 
to 0.5 platelets per PMN, we determined whether the 
PKCC signal was due to platelet contamination. Western 
blots were performed on platelet cytosol using antipep- 
tide antibodies specific to PKCol and -c. As shown in 
Fig. 2, the PKCC signal was intense in both PMN and 
platelets, while the PKCcl signal was weak in PMN and 
strong in platelets, as reported previously [24]. These 
data indicate that the PKCC signal observed with the 
antibody against PKCC derives predominantly from 
PMN, not contaminating platelets. 
PMA is a potent stimulant of PMN functions such as 
respiratory burst and exocytosis [llL14] and has been 
shown to induce PKC translocation from the cytosol to 
membrane fraction, a phenomenon which has been cor- 
related with the respiratory burst [l 11. To determine the 
possible involvement of PKCC in PMN functions, we 
examined the distribution of PKCC in PMA-stimulated 
PMN. As shown in Fig. 3, short stimulation (5 min, 
37°C) of PMN with a PMA concentration that causes 
superoxide production [ 1 l] induced physical transloca- 
tion of PKC[ from the cytosol to the plasma membrane, 
although this isoform does not bind phorbol esters [25]. 
4. Discussion 
Our data confirm the presence of the two conventional 
calcium-dependent cPKC isoforms, tl and /?, in human 
PMN [15-171. We also provide the first evidence that 
human PMN express an atypical calcium-independent 
PKC isoform, 5, which was detected as two major com- 
ponents in the cytosolic fraction of resting PMN. The 
other PKC isoforms studied here, PKCG, -E, and -y were 
undetectable, in agreement with other work [18]. It 
should be noted that detection of PKC isozymes is de- 
pendent on the characteristics of the antibodies used and 
the isoenzyme concentration. Other newly described cal- 
cium-independent PKC isoforms which were not studied 
here, such as q, 8, ;1,1 and p, may also have been present, 
as suggested by the work of Majumdar et al. [18], who 
characterized a calcium-independent kinase, termed 
nPKC, which requires both PS and DG for optimal ac- 
tivity. This nPKC was not recognized by an antibody 
directed against PKC[, although the authors mentioned 
the presence of [. PKCC and -p but not PKCcl were also 
identified in bovine PMN [26]. 
The relative expression of the different protein 
isoforms is difficult to determine by the Western blot 
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Fig. 3. PMA-induced translocation of PKa from PMN cytosol to 
plasma membrane. Cells (50 x IO6 PMN/ml) were exposed to 1 pg/ml 
PMA or 0.1% DMSO (control) for 5 min at 37°C. Cytosol (c) and 
membrane (m) proteins was subjected to SDS-PAGE (50,~g of protein/ 
lane for cytosolic fraction and 80 pg of protein/lane for membrane 
fraction) and immunoblotted with an antibody against PKCC. 
technique, on account of differences in the titer and hy- 
bridization efficiencies of the respective antibodies. 
However, densitometric analysis of autoradiograms 
from immunoblots incubated with the same dilution of 
antibodies and developed after the same exposure, indi- 
cated that aPKCC may be expressed as abundantly as the 
p isoform, suggesting that it may play a role in PMN 
biological responses. This is further supported by the 
observation that stimulation of PMN with PMA induced 
a rapid (30 s, not shown) displacement of PKCC to the 
plasma membrane (Fig. 3). The PMA concentration used 
(1 @ml) also induces superoxide anion production and 
degranulation of primary granules, which supports the 
role of PKCC in these processes [l 11. PKCol and PKC/I 
were also shown to translocate after cell stimulation with 
PMA [16,17,27] and may play an important role in the 
regulation of PMN functions. Whether the isoforms act 
sequentially or synergistically remains to be determined. 
The finding that aPKC[ translocates from the cytosol 
to the plasma membrane in PMA-stimulated PMN is 
interesting, given that this isoform neither binds nor is 
activated by phorbol esters [25]. Translocation of this 
PKC isoform has also been reported in rat R6 embryo 
fibroblasts [28], human platelets [24,29] and smooth 
muscle cells [31]. The translocated PKCC was extracted 
by Triton X-100, indicating that it may share the charac- 
teristics of membrane ‘inserted’ form of PKC [8-lo]. 
Possible mechanisms of PKCC redistribution include in- 
teraction of the PKC-binding domain with membrane- 
associated PKC-binding proteins [3 l-331 which may 
serve to anchor and compartmentalize PKC isoenzymes. 
PKC[ may be associated with the membrane through 
these proteins. It has been also proposed that aPKCc 
may have preserved a low-affinity binding site for phor- 
bol esters in its single cysteine-rich domain and that high 
doses of PMA would trigger its redistribution. This hy- 
pothesis is supported by the binding of phorbol esters to 
a PKCy mutant containing one set of cysteine-rich mo- 
tifs with a structure similar to that of PKCC [34,35]. 
However, in PKCC, this motif differs in a single residue 
from the consensus (proline in position 11 of the motif). 
Restoration of this proline by site-directed mutagenesis 
of PKCC does not restore phorbol ester binding, suggest- 
ing that other amino acid residues besides the postulated 
consensus may be necessary for binding [36]. 
The physiological role of PKC[, as well the mecha- 
nisms by which the enzyme is activated in intact cells, 
remains unclear. However, it has recently been shown 
that phosphatidylinositol 3,4,5_trisphosphate (PIP3) can 
activate PKCC in vitro [37]. PIP3 might be a physiologi- 
cal activator of PKCC in PMN, since stimulation of these 
cells by formylated peptides triggers the activation of 
PI3-kinase, which phosphorylates phosphatidyl inositol 
4,5-biphosphate (PIP2) to form PIP3 [38]. A role of PIP3 
in PMN biological functions is further suggested by the 
observation that wortmanin, an inhibitor of PI3-kinase 
[39], depresses the PMN respiratory burst mediated by 
formyl peptides [40]. 
In conclusion, our data provide evidence that human 
PMN express substantial amounts of PKCC, mainly in 
soluble form. Stimulation of PMN by phorbol esters 
triggers redistribution of PKCC raising the possibility 
that PKCC, plays a role in the regulation of PMN anti- 
bacterial activities. The mechanism leading to PKCC ac- 
tivation, as well as its physiological significance, requires 
further studies. 
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